Obesity Featured Articles

  1. Everyone Is A Consultant Now 8/19/2026

    Jon Newton argues clinical research’s “vanishing middle” is giving rise to a more flexible workforce of consultants, specialists, and boutique firms.

  2. Rare Disease Study Gets A Boost From Crowdsourced Patient Reported Data 8/18/2026

    Jen A. Levitt, MD, explains how crowdsourced patient-reported data and AI tools can compress rare disease research timelines and surface new signals.

  3. Challenges And Opportunities In Lung Cancer Clinical Development 8/17/2026

    Discover how precision medicine and novel therapeutics reshape lung cancer clinical development. Gain insights to overcome modern trial execution and global enrollment challenges.

  4. Clinical Trial Logistics: What Biopharma Needs To Prepare For Next 8/17/2026

    Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.

  5. What The Sponsor–CRO Relationship Gets Wrong — On Both Sides 8/17/2026

    The CRO's value is not execution alone. It is the depth of perspective that comes from having seen hundreds of trials across disease areas and regulatory environments. 

  6. The U.S. Clinical Trial Recruiting Pipeline Report – July 2026 8/17/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from June through July 2026.

  7. Examining The New Look For Biotech 8/14/2026

    According to a recent episode of Citeline’s podcast series, “Small Biotechs, Big Decisions,” biotech is developing a new look that is leaner and savvier when it comes to working with partners.

  8. How AI Is Revolutionizing Clinical Development 8/14/2026

    Artificial intelligence is expanding from the preclinical phase of clinical trials into Phases I–III, where is it being used in protocol design, site selection, feasibility, and patient recruitment.

  9. Under Half Of CTIS Trials Met Results Reporting Requirements 8/14/2026

    A first assessment of compliance on EU Clinical Trial Information System (CTIS) found fewer than half of European Phase II–IV drug trials legally required to post results fully complied on time.

  10. The Art And Skill Of Caring For Terminally Ill Patients In Clinical Research And Beyond 8/14/2026

    When designing and conducting trials for terminally ill patients, Kamila Novak reminds researchers to act and speak with respect, warmth, and thoughtfulness.